Back
Apellis Pharmaceuticals Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
45
APLS
Apellis Pharmaceuticals
Last Price:
$18.57
Seasonality Move:
0.23%
7 Day Trial
ALL ACCESS PASS
$
7
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.-
The current trend is relatively stagnant and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.65 | Buy |
| 20-day SMA: | 17.62 | Buy |
| 50-day SMA: | 19.15 | Sell |
| 200-day SMA: | 28 | Sell |
| 8-day EMA: | 17.92 | Buy |
| 20-day EMA: | 17.93 | Buy |
| 50-day EMA: | 19.59 | Sell |
| 200-day EMA: | 28.02 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 53.88 | Buy |
| Chaikin Money Flow: | -1855597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.92 - 19.1) | Buy |
| Bollinger Bands (100): | (18.54 - 28.54) | Sell |
Apellis Pharmaceuticals Technical Analysis
| May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.82 while APLS 8-day simple moving average is 17.65, which is a Buy signal.
-
The stock price of APLS is 18.82 while Apellis Pharmaceuticals 20-day SMA is 17.62, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day simple moving average is 19.15 while APLS share price is 18.82, making it a Sell technically.
-
APLS stock price is 18.82 and Apellis Pharmaceuticals 200-day simple moving average is 28.00, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
45
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $18.82. The Score for APLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.4B
Price in USD:
18.82
Share Volume:
1.9M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
43.76
52-Week Low:
16.10
Sell
45
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 18.82 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.82 while APLS 8-day exponential moving average is 17.92, which is a Buy signal.
-
The stock price of APLS is 18.82 while Apellis Pharmaceuticals 20-day EMA is 17.93, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 19.59 while APLS share price is 18.82, making it a Sell technically.
-
APLS stock price is 18.82 and Apellis Pharmaceuticals 200-day simple moving average is 28.02, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.17 per share, and an increase next year of $1.21 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 53.88, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (16.92 - 19.1), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (18.54 - 28.54), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.